Hsp10 and Hsp60 suppress ubiquitination of insulin-like growth factor-1 receptor and augment insulin-like growth factor-1 receptor signaling in cardiac muscle - Implications on decreased myocardial protection in diabetic cardiomyopathy

被引:73
作者
Shan, YX
Yang, TL
Mestril, R
Wang, PH
机构
[1] Univ Calif Irvine, Ctr Cardiovasc Hormone Res, Dept Med Biol Chem Physiol & Biophys, Irvine, CA 92697 USA
[2] First Med Univ, Nanfang Hosp, Dept Med, Guangzhou 510515, Peoples R China
[3] Loyola Univ, Dept Physiol, Maywood, IL 60153 USA
关键词
D O I
10.1074/jbc.M304498200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We have investigated the effects of two heat shock proteins, Hsp10 and Hsp60, on insulin-like growth factor-1 receptor (IGF-1R) signaling in cardiac muscle cells. Neonatal cardiomyocytes were transduced with Hsp10 or Hsp60 via adenoviral vector. Compared with the cells transduced with a control vector, overexpression of Hsp10 or Hsp60 increased the abundance of IGF-1R and IGF-1-stimulated receptor autophosphorylation. Thus, Hsp10 and Hsp60 overexpression increased the number of functioning receptors and amplified activation of IGF-1R signaling. IGF-1 stimulation of MEK, Erk, p90Rsk, and Akt were accordingly augmented. Transducing cardiomyocytes with antisense Hsp60 oligonucleotides reduced Hsp60 expression, decreased the abundance of IGF-1R, attenuated IGF-1R autophosphorylation, and suppressed the pro-survival action of IGF-1 in cardiomyocytes. Using cycloheximide to inhibit protein synthesis did not alter the effect of Hsp60 on IGF-1R signaling, and IGF-1R mRNA levels were not up-regulated by Hsp10 or Hsp60. Additional experiments showed that Hsp10 and Hsp60 suppressed polyubiquitination of IGF-1 receptor. These data indicate that Hsp10 and Hsp60 can modulate IGF-1R signaling through post-translational modification. In animal models of diabetes, diabetic myocardium is associated with decreased abundance of Hsp60, increased ubiquitination of IGF-1R, and lower level of IGF-1R protein. Declined myocardial protection is a major feature of diabetic cardiomyopathy. These data suggest that decreased Hsp60 expression and subsequent decline of IGF-1R signaling may be a fundamental mechanism underlying the development of diabetic cardiomyopathy.
引用
收藏
页码:45492 / 45498
页数:7
相关论文
共 25 条
  • [1] Barazi HO, 2002, CANCER RES, V62, P1541
  • [2] Akt forms an intracellular complex with heat shock protein 90 (Hsp90) and Cdc37 and is destabilized by inhibitors of Hsp90 function
    Basso, AD
    Solit, DB
    Chiosis, G
    Giri, B
    Tsichlis, P
    Rosen, N
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) : 39858 - 39866
  • [3] Ansamycin antibiotics inhibit Akt activation and cyclin D expression in breast cancer cells that overexpress HER2
    Basso, AD
    Solit, DB
    Munster, PN
    Rosen, N
    [J]. ONCOGENE, 2002, 21 (08) : 1159 - 1166
  • [4] CONDORELLI G, 1994, J BIOL CHEM, V269, P8510
  • [5] Geldanamycin, a heat shock protein 90-binding steroid-dependent translocation of the glucocorticoid receptor from the cytoplasm to the nucleus
    Czar, MJ
    Galigniana, MD
    Silverstein, AM
    Pratt, WB
    [J]. BIOCHEMISTRY, 1997, 36 (25) : 7776 - 7785
  • [6] Insulin induces heterologous desensitization of G protein-coupled receptor and insulin-like growth factor I signaling by downregulating β-arrestin-1
    Dalle, S
    Imamura, T
    Rose, DW
    Worrall, DS
    Ugi, S
    Hupfeld, CJ
    Olefsky, JM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2002, 22 (17) : 6272 - 6285
  • [7] Cytosolic heat shock protein 60, hypoxia, and apoptosis
    Gupta, S
    Knowlton, AA
    [J]. CIRCULATION, 2002, 106 (21) : 2727 - 2733
  • [8] Induction of mitochondrial heat shock protein 60 and 10 mRNAs following transient focal cerebral ischemia in the rat
    Izaki, K
    Kinouchi, H
    Watanabe, K
    Owada, Y
    Okubo, A
    Itoh, H
    Kondo, H
    Tashima, Y
    Tamura, S
    Yoshimoto, T
    Mizoi, K
    [J]. MOLECULAR BRAIN RESEARCH, 2001, 88 (1-2): : 14 - 25
  • [9] IGF-1 overexpression inhibits the development of diabetic cardiomyopathy and angiotensin II-mediated oxidative stress
    Kajstura, J
    Fiordaliso, F
    Andreoli, AM
    Li, BS
    Chimenti, S
    Medow, MS
    Limana, F
    Nadal-Ginard, B
    Leri, A
    Anversa, P
    [J]. DIABETES, 2001, 50 (06) : 1414 - 1424
  • [10] Signalling through IGF-I and insulin receptors: where is the specificity?
    Kim, JJ
    Accili, D
    [J]. GROWTH HORMONE & IGF RESEARCH, 2002, 12 (02) : 84 - 90